Australia markets open in 9 hours 53 minutes

Bausch Health Companies Inc. (BHCN.MX)

Mexico - Mexico Delayed price. Currency in MXN
Add to watchlist
134.340.00 (0.00%)
At close: 08:57AM CST

Bausch Health Companies Inc.

2150 St. ElzEar Boulevard West
Laval, QC H7L 4A8

IndustryDrugs - Generic
Full-time employees19,900

Key executives

NameTitlePayExercisedYear born
Mr. Thomas J. AppioCEO & Director2.9MN/A1962
Mr. Thomas G. VadakethExec. VP & CFON/AN/A1963
Mr. Mirza DautbegovicSr. VP & COON/AN/AN/A
Mr. John S. BarresiSr. VP, Controller & Chief Accounting OfficerN/AN/A1973
Dr. Robert F. ButzVP of Medical & Scientific AffairsN/AN/AN/A
Mr. Arthur J. ShannonSr. VP and Head of Investor Relations & Global CommunicationsN/AN/AN/A
Ms. Seana CarsonExec. VP & Gen. CounselN/AN/A1972
Ms. Kathleen FitzpatrickSr. VP & Chief HR OfficerN/AN/AN/A
Dr. Tage Ramakrishna M.D.Chief Medical Officer and Pres of R&DN/AN/A1974
Mr. Jeff HartnessSr. VP of Market Access, Commercial Operations & Gov. AffairsN/AN/AN/A
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in MXN.


Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Latin America, Africa, and the Middle East. The Solta Medical segment offers medical devices. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic, dermatological, and dentistry products in the United States. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Corporate governance

Bausch Health Companies Inc.’s ISS governance QualityScore as of 1 March 2023 is 5. The pillar scores are Audit: 4; Board: 3; Shareholder rights: 3; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.